Page 6 - Slide 1

Disclosure of Commercial Support

Potential for conflict(s) of interest:

• This program has received funding from Bayer Inc. and

Sanofi Canada in the form of an educational grant

• Bayer and Sanofi manufacture products in therapeutic

categories that will be discussed in this program; specific

product mentions include: cabazitaxel (Sanofi),

darolutamide (Bayer), and radium-223 (Bayer)

6